Hope or hype: the obsession with medical advances and the high cost of false promises
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York
AMACOM, American Management Association
©2005
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references (pages 291-326) and index Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making Annotation |
| Beschreibung: | 1 Online-Ressource (xvi, 335 pages) |
| ISBN: | 0814428592 9780814408452 9780814428597 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043097377 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2005 |||| o||u| ||||||eng d | ||
| 020 | |a 0814428592 |c electronic bk. |9 0-8144-2859-2 | ||
| 020 | |a 9780814408452 |9 978-0-8144-0845-2 | ||
| 020 | |a 9780814428597 |c electronic bk. |9 978-0-8144-2859-7 | ||
| 035 | |a (OCoLC)57929103 | ||
| 035 | |a (DE-599)BVBBV043097377 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 610/.28 |2 22 | |
| 100 | 1 | |a Deyo, Richard A. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Hope or hype |b the obsession with medical advances and the high cost of false promises |c Richard A. Deyo, Donald L. Patrick |
| 264 | 1 | |a New York |b AMACOM, American Management Association |c ©2005 | |
| 300 | |a 1 Online-Ressource (xvi, 335 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (pages 291-326) and index | ||
| 500 | |a Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making | ||
| 500 | |a Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making | ||
| 500 | |a Annotation | ||
| 650 | 7 | |a TECHNOLOGY & ENGINEERING / Biomedical |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Family & General Practice |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Allied Health Services / Medical Technology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Biotechnology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Lasers in Medicine |2 bisacsh | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Medical innovations |z United States |x Evaluation | |
| 650 | 4 | |a Medical technology |z United States |x Evaluation | |
| 650 | 4 | |a Medical care |x Technological innovations |z United States |x Evaluation | |
| 650 | 4 | |a Medical care |z United States |x Evaluation | |
| 650 | 4 | |a Medical innovations |x Economic aspects |z United States | |
| 650 | 4 | |a Medical technology |z United States |x Cost effectiveness | |
| 650 | 4 | |a Medical care |x Technological innovations |z United States |x Cost effectiveness | |
| 650 | 4 | |a Medical care, Cost of |z United States | |
| 650 | 0 | 7 | |a Sozialer Ertrag |0 (DE-588)4262264-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Medizin |0 (DE-588)4038243-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitswesen |0 (DE-588)4020775-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Medizinschaden |0 (DE-588)4201836-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wissenschaftlich-technischer Fortschritt |0 (DE-588)4132508-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Medizin |0 (DE-588)4038243-6 |D s |
| 689 | 0 | 1 | |a Wissenschaftlich-technischer Fortschritt |0 (DE-588)4132508-4 |D s |
| 689 | 0 | 2 | |a Medizinschaden |0 (DE-588)4201836-5 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Medizin |0 (DE-588)4038243-6 |D s |
| 689 | 1 | 1 | |a Wissenschaftlich-technischer Fortschritt |0 (DE-588)4132508-4 |D s |
| 689 | 1 | 2 | |a Sozialer Ertrag |0 (DE-588)4262264-5 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 689 | 2 | 0 | |a Medizin |0 (DE-588)4038243-6 |D s |
| 689 | 2 | 1 | |a Wissenschaftlich-technischer Fortschritt |0 (DE-588)4132508-4 |D s |
| 689 | 2 | 2 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 2 | |8 3\p |5 DE-604 | |
| 689 | 3 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 3 | 1 | |a Gesundheitswesen |0 (DE-588)4020775-4 |D s |
| 689 | 3 | 2 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 3 | |8 4\p |5 DE-604 | |
| 700 | 1 | |a Patrick, Donald L. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-8144-0845-1 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=117775 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028521569 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=117775 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=117775 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175503914958848 |
|---|---|
| any_adam_object | |
| author | Deyo, Richard A. |
| author_facet | Deyo, Richard A. |
| author_role | aut |
| author_sort | Deyo, Richard A. |
| author_variant | r a d ra rad |
| building | Verbundindex |
| bvnumber | BV043097377 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)57929103 (DE-599)BVBBV043097377 |
| dewey-full | 610/.28 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610/.28 |
| dewey-search | 610/.28 |
| dewey-sort | 3610 228 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07499nmm a2200913zc 4500</leader><controlfield tag="001">BV043097377</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2005 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0814428592</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-8144-2859-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780814408452</subfield><subfield code="9">978-0-8144-0845-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780814428597</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-8144-2859-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)57929103</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043097377</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610/.28</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Deyo, Richard A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hope or hype</subfield><subfield code="b">the obsession with medical advances and the high cost of false promises</subfield><subfield code="c">Richard A. Deyo, Donald L. Patrick</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">AMACOM, American Management Association</subfield><subfield code="c">©2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvi, 335 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 291-326) and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Annotation</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING / Biomedical</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Family & General Practice</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Allied Health Services / Medical Technology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Biotechnology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Lasers in Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical innovations</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical technology</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care</subfield><subfield code="x">Technological innovations</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical innovations</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical technology</subfield><subfield code="z">United States</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care</subfield><subfield code="x">Technological innovations</subfield><subfield code="z">United States</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care, Cost of</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sozialer Ertrag</subfield><subfield code="0">(DE-588)4262264-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizinschaden</subfield><subfield code="0">(DE-588)4201836-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wissenschaftlich-technischer Fortschritt</subfield><subfield code="0">(DE-588)4132508-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wissenschaftlich-technischer Fortschritt</subfield><subfield code="0">(DE-588)4132508-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Medizinschaden</subfield><subfield code="0">(DE-588)4201836-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Wissenschaftlich-technischer Fortschritt</subfield><subfield code="0">(DE-588)4132508-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Sozialer Ertrag</subfield><subfield code="0">(DE-588)4262264-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Wissenschaftlich-technischer Fortschritt</subfield><subfield code="0">(DE-588)4132508-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patrick, Donald L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-8144-0845-1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=117775</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028521569</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=117775</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=117775</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV043097377 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:20Z |
| institution | BVB |
| isbn | 0814428592 9780814408452 9780814428597 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028521569 |
| oclc_num | 57929103 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xvi, 335 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | AMACOM, American Management Association |
| record_format | marc |
| spelling | Deyo, Richard A. Verfasser aut Hope or hype the obsession with medical advances and the high cost of false promises Richard A. Deyo, Donald L. Patrick New York AMACOM, American Management Association ©2005 1 Online-Ressource (xvi, 335 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (pages 291-326) and index Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making Annotation TECHNOLOGY & ENGINEERING / Biomedical bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Lasers in Medicine bisacsh Medizin Medical innovations United States Evaluation Medical technology United States Evaluation Medical care Technological innovations United States Evaluation Medical care United States Evaluation Medical innovations Economic aspects United States Medical technology United States Cost effectiveness Medical care Technological innovations United States Cost effectiveness Medical care, Cost of United States Sozialer Ertrag (DE-588)4262264-5 gnd rswk-swf Medizin (DE-588)4038243-6 gnd rswk-swf Gesundheitswesen (DE-588)4020775-4 gnd rswk-swf Medizinschaden (DE-588)4201836-5 gnd rswk-swf Wissenschaftlich-technischer Fortschritt (DE-588)4132508-4 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf Medizin (DE-588)4038243-6 s Wissenschaftlich-technischer Fortschritt (DE-588)4132508-4 s Medizinschaden (DE-588)4201836-5 s 1\p DE-604 Sozialer Ertrag (DE-588)4262264-5 s 2\p DE-604 Kosten-Nutzen-Analyse (DE-588)4032589-1 s 3\p DE-604 USA (DE-588)4078704-7 g Gesundheitswesen (DE-588)4020775-4 s 4\p DE-604 Patrick, Donald L. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 0-8144-0845-1 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=117775 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Deyo, Richard A. Hope or hype the obsession with medical advances and the high cost of false promises TECHNOLOGY & ENGINEERING / Biomedical bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Lasers in Medicine bisacsh Medizin Medical innovations United States Evaluation Medical technology United States Evaluation Medical care Technological innovations United States Evaluation Medical care United States Evaluation Medical innovations Economic aspects United States Medical technology United States Cost effectiveness Medical care Technological innovations United States Cost effectiveness Medical care, Cost of United States Sozialer Ertrag (DE-588)4262264-5 gnd Medizin (DE-588)4038243-6 gnd Gesundheitswesen (DE-588)4020775-4 gnd Medizinschaden (DE-588)4201836-5 gnd Wissenschaftlich-technischer Fortschritt (DE-588)4132508-4 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd |
| subject_GND | (DE-588)4262264-5 (DE-588)4038243-6 (DE-588)4020775-4 (DE-588)4201836-5 (DE-588)4132508-4 (DE-588)4032589-1 (DE-588)4078704-7 |
| title | Hope or hype the obsession with medical advances and the high cost of false promises |
| title_auth | Hope or hype the obsession with medical advances and the high cost of false promises |
| title_exact_search | Hope or hype the obsession with medical advances and the high cost of false promises |
| title_full | Hope or hype the obsession with medical advances and the high cost of false promises Richard A. Deyo, Donald L. Patrick |
| title_fullStr | Hope or hype the obsession with medical advances and the high cost of false promises Richard A. Deyo, Donald L. Patrick |
| title_full_unstemmed | Hope or hype the obsession with medical advances and the high cost of false promises Richard A. Deyo, Donald L. Patrick |
| title_short | Hope or hype |
| title_sort | hope or hype the obsession with medical advances and the high cost of false promises |
| title_sub | the obsession with medical advances and the high cost of false promises |
| topic | TECHNOLOGY & ENGINEERING / Biomedical bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Lasers in Medicine bisacsh Medizin Medical innovations United States Evaluation Medical technology United States Evaluation Medical care Technological innovations United States Evaluation Medical care United States Evaluation Medical innovations Economic aspects United States Medical technology United States Cost effectiveness Medical care Technological innovations United States Cost effectiveness Medical care, Cost of United States Sozialer Ertrag (DE-588)4262264-5 gnd Medizin (DE-588)4038243-6 gnd Gesundheitswesen (DE-588)4020775-4 gnd Medizinschaden (DE-588)4201836-5 gnd Wissenschaftlich-technischer Fortschritt (DE-588)4132508-4 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd |
| topic_facet | TECHNOLOGY & ENGINEERING / Biomedical MEDICAL / Family & General Practice MEDICAL / Allied Health Services / Medical Technology MEDICAL / Biotechnology MEDICAL / Lasers in Medicine Medizin Medical innovations United States Evaluation Medical technology United States Evaluation Medical care Technological innovations United States Evaluation Medical care United States Evaluation Medical innovations Economic aspects United States Medical technology United States Cost effectiveness Medical care Technological innovations United States Cost effectiveness Medical care, Cost of United States Sozialer Ertrag Gesundheitswesen Medizinschaden Wissenschaftlich-technischer Fortschritt Kosten-Nutzen-Analyse USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=117775 |
| work_keys_str_mv | AT deyoricharda hopeorhypetheobsessionwithmedicaladvancesandthehighcostoffalsepromises AT patrickdonaldl hopeorhypetheobsessionwithmedicaladvancesandthehighcostoffalsepromises |